Clinical Trials in Massachusetts

Showing 7501-7520 of 13,570 trials

Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions

NCT03224520

The research study, "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions" will test two smoker-driven, social marketing innovations to recruit and engage smokers in Decide2Quit.org (Decide2Quit), which is an evidence-based, effective "Digital Intervention for Smoking Cessation".

Smoking Cessation

University of Massachusetts, Worcester1,487 participantsStarted Dec 2017

Worcester, Massachusetts, United States

COMPLETED18 miles

GLORIA-AF Registry Program - Second and Third Phases

NCT01468701

In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purposes the study is divided into two protocol numbers: 1160.129 for all non-EU (European Union) and non-EEA (European Economic Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.

StrokeAtrial Fibrillation

Boehringer Ingelheim37,235 participantsStarted Nov 2011

Mobile, Alabama, United States • Northport, Alabama, United States • Scottsboro, Alabama, United States +663 more locations

Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions

GLORIA-AF Registry Program - Second and Third Phases

Find Trials by Condition in Massachusetts

The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety

Cerebral Excitability and Cognitive Performance

Validation of a Totally Synthetic High Fidelity Laparoscopic Duodenal Atresia (DA) Surgical Simulator

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders

The Diet Gout Trial

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed)

Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus

Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)

IN.PACT Global Clinical Study

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Strategy for Maintenance of HIV Suppression With Once Daily Integrate Inhibitor+Darunavir/Ritonavir in Children